WeVote
Log In

Bill

Bill

S 1318

Fallen Servicemembers Religious Heritage Restoration Act

119th Congress Introduced by Jim Banks and 20 co-sponsors

Bill S 1318 continues the Empire State Stem Cell Board, ensuring ongoing funding and support for stem cell research, benefiting scientists, healthcare providers, and patients.

Motion to proceed to consideration of the House message to accompany S. 1318 rejected in Senate by Yea-Nay Vote. 47 - 52. Record Vote Number: 164.
0
WeVote Research Nonpartisan
Bill Summary · S 1318

Summary of Bill S 1318: Continuation of the Empire State Stem Cell Board

Overview

Bill S 1318 is a legislative proposal aimed at continuing the operations of the Empire State Stem Cell Board. This board plays a crucial role in overseeing stem cell research and funding initiatives within the state. The bill was introduced on January 9, 2025, and has been referred to the Health Committee for further consideration.

Purpose and Intent

The primary purpose of Bill S 1318 is to ensure the ongoing support and governance of stem cell research in New York. By continuing the Empire State Stem Cell Board, the bill seeks to promote scientific advancements in regenerative medicine, enhance public health, and foster economic growth through innovative research initiatives.

Key Provisions

  • Continuation of the Board: The bill proposes to extend the existence of the Empire State Stem Cell Board, which is responsible for managing state-funded stem cell research programs.
  • Funding Oversight: The board will continue to oversee the allocation of funds for stem cell research projects, ensuring that resources are directed towards promising scientific endeavors.
  • Research Promotion: The bill emphasizes the importance of promoting stem cell research and its applications in treating various medical conditions, thereby supporting advancements in healthcare.

Affected Parties

  • Researchers and Scientists: The bill directly impacts researchers and scientists engaged in stem cell research, providing them with continued access to funding and resources.
  • Healthcare Providers: By fostering advancements in regenerative medicine, healthcare providers may benefit from new treatments and therapies developed through funded research.
  • Patients: Individuals suffering from conditions that could be treated with stem cell therapies stand to gain from the ongoing research and development supported by the board.

Procedural Aspects

  • Introduced Date: The bill was introduced on January 9, 2025.
  • Current Status: As of now, the bill has been referred to the Health Committee, where it will undergo further review and discussion before any potential voting or amendments.

Related Legislation

Bill S 1318 is related to prior-session bills, including:
- S 6623: A previous bill that may have addressed similar issues regarding stem cell research.
- S 554: Another prior-session bill that could provide context or background relevant to the current proposal.

Conclusion

Bill S 1318 represents a significant step towards the continuation of vital stem cell research in New York. By maintaining the Empire State Stem Cell Board, the bill aims to support scientific innovation, improve healthcare outcomes, and enhance the state's position as a leader in medical research. The bill is currently under consideration by the Health Committee, and its progress will be closely monitored by stakeholders in the scientific and medical communities.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.